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Abstract. 
 
Cyclin A is a stable protein in S and G2
phases, but is destabilized when cells enter mitosis and
is almost completely degraded before the metaphase
to anaphase transition. Microinjection of antibodies
against subunits of the anaphase-promoting complex/
cyclosome (APC/C) or against human Cdc20 (ﬁzzy) ar-
rested cells at metaphase and stabilized both cyclins A
and B1. Cyclin A was efﬁciently polyubiquitylated by
Cdc20 or Cdh1-activated APC/C in vitro, but in contrast
to cyclin B1, the proteolysis of cyclin A was not delayed
by the spindle assembly checkpoint. The degradation of
cyclin B1 was accelerated by inhibition of the spindle as-
sembly checkpoint. These data suggest that the APC/C is
activated as cells enter mitosis and immediately targets
cyclin A for degradation, whereas the spindle assembly
checkpoint delays the degradation of cyclin B1 until the
metaphase to anaphase transition. The “destruction
box” (D-box) of cyclin A is 10–20 residues longer than
that of cyclin B. Overexpression of wild-type cyclin A
delayed the metaphase to anaphase transition, whereas
expression of cyclin A mutants lacking a D-box ar-
rested cells in anaphase.
Key words: cyclin A • ubiquitin • APC/C • spindle as-
sembly checkpoint • mitosis
 
Introduction
 
Cyclin A is an essential gene in 
 
Drosophila
 
 and mice
(Lehner and O’Farrell, 1989; Murphy et al., 1997). In
 
Drosophila
 
,
 
 
 
the single cyclin A activates Cdk1 and is es-
sential for entry into mitosis (Lehner and O’Farrell, 1989;
Knoblich and Lehner, 1993). In 
 
Xenopus
 
 (Minshull et al.,
1990; Howe et al., 1995), mice (Sweeney et al., 1996), and
humans (Yang et al., 1997), two versions of cyclin A ex-
ist, both of which can form complexes with either Cdk1
or Cdk2. Cyclin A1 is only expressed in meiosis and very
early embryos, whereas cyclin A2 is found in proliferat-
ing somatic cells. The only essential function of cyclin A1
in mice occurs in spermatogenesis (Liu et al., 1998),
whereas deletion of the somatic form of cyclin A causes
embryonic lethality (Murphy et al., 1997). The precise
function of somatic cyclin A is not well defined, and roles
in both S phase and mitosis have been suggested (Girard
et al., 1991; Pagano et al., 1992; Cardoso et al., 1993;
Krude et al., 1997; Furuno et al., 1999; Jiang et al., 1999;
Petersen et al., 1999). In cultured cells, cyclin A starts to
be detectable as cells enter S phase, and its level increases
throughout S and G2 phase, peaking in early mitosis
(Pines and Hunter, 1990; Poon et al., 1994; Erlandsson et
al., 2000). It is rapidly degraded during mitosis, undergo-
ing proteolytic destruction before the B-type cyclins
(Minshull et al., 1990; Whitfield et al., 1990; Hunt et al.,
1992; Sigrist et al., 1995; Kramer et al., 2000). In addition
to cyclins, securins must be degraded to allow the onset
of anaphase (Cohen-Fix et al., 1996; Funabiki et al., 1996;
 
Zou et al., 1999). All of these proteins are degraded
 
by ubiquitin-mediated delivery to the proteasome, which
requires a dedicated ubiquitin ligase called the ana-
 
phase-promoting complex/cyclosome (APC/C)
 
1
 
 (for re-
view see Peters, 1999). Substrates for the APC/C carry
one or more short sequences in their NH
 
2
 
 terminus
called a destruction box (D-box) (Glotzer et al., 1991).
The degradation of 
 
Xenopus laevis
 
 cyclin A1 not only re-
quires a functional D-box but also correct folding to allow
binding to Cdk1 or 2, and unlike that of cyclin B1, the D-box
of frog cyclin A1 cannot act as an independent destruction
module when grafted onto heterologous proteins (King et al.,
1996; Klotzbücher et al., 1996).
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The activation of the APC/C in mitosis involves phos-
phorylation (Rudner and Murray, 2000) and also requires
Cdc20/fizzy (for review see Zachariae and Nasmyth, 1999).
Inhibition of or inactivating mutations in the APC/C arrest
cells at metaphase and stabilize both securin and cyclin
(Holloway et al., 1993; Irniger et al., 1995; King et al., 1995;
Tugendreich et al., 1995; Cohen-Fix et al., 1996). Because
premature activation of the APC/C may cause unequal
chromosome segregation, its activation is further regu-
lated by the spindle assembly checkpoint which monitors
the attachment of microtubules to kinetochores and delays
the activation of the APC/C until all chromosomes are
properly attached to the mitotic spindle (Rudner and Mur-
ray, 1996). When activated, this checkpoint mediates the
inhibition of the APC/C by the action of Mad2 (Li et al.,
1997; Fang et al., 1998a).
In 
 
Drosophila
 
, the Cdc20 homologue 
 
fizzy
 
 (
 
fzy
 
) is re-
quired for the degradation of both cyclins A and B (Daw-
son et al., 1995; Sigrist et al., 1995), indicating that the same
destruction machinery acts on both cyclins. Nevertheless,
their degradation is differentially regulated as cyclin A dis-
appears before cyclin B. Furthermore, when embryos are
exposed to colchicine, cyclin B but not cyclin A is stabi-
lized (Whitfield et al., 1990). In 
 
Drosophila
 
, the proteolysis
of cyclin A is essential for progression through mitosis,
since expression of stable cyclin A arrests cells (tran-
siently) at metaphase (Sigrist et al., 1995), whereas expres-
sion of stable cyclin B arrests cells at later stages of mitosis
(Holloway et al., 1993; Surana et al., 1993; Rimmington et
al., 1994; Sigrist et al., 1995; Yamano et al., 1996).
In this paper, we show that human cyclin A is a rela-
tively stable protein during S and G2 phase, but becomes
extremely short lived when cells enter mitosis. We show
that microinjection of antibodies against the APC/C stabi-
lizes cyclin A and arrests cells in metaphase. We define a
novel D-box for cyclin A and find that expression of wild-
type cyclin A delays the onset of anaphase by a mecha-
nism which requires a functional D-box but not associated
kinase activity. By contrast, expression of indestructible
mutants of cyclin A with high kinase activity arrests cells
in anaphase. We also show that, unlike the proteolysis of
the B-type cyclins, that of cyclin A is not sensitive to the
spindle assembly checkpoint.
 
Materials and Methods
 
Cell Culture and Transfections
 
Cells were grown in E4 medium supplemented with 10% bovine calf
serum, 100 U/ml penicillin, 100 
 
m
 
g/ml streptomycin, and 2 
 
m
 
g/ml butyl-
 
p
 
-hydroxybenzoate at 37
 
8
 
C, 6% CO
 
2
 
, and saturated humidity. HeLa
(clone Ohio) and HTB96 (U2OS) cells were synchronized by double thy-
midine block or mitotic shake-off after nocodazole treatment as de-
scribed by Krek and DeCaprio (1995). For microinjection experiments,
cells were injected 6–8 h after release from the second thymidine block.
For transient transfections (efficiency 30–50%), unsynchronized cells were
transfected using Superfect (QIAGEN) following the manufacturer’s in-
structions. For stable transfections, HTB96 cells were transfected with 10
 
m
 
g plasmid using a modified CaPO
 
4
 
 coprecipitation method (Pear et al.,
1993). The tetracycline-inducible cell line ONK2 was generated by trans-
fecting HTB96 cells with pUHG17-1 (Gossen et al., 1995) (a gift from H.
Bujard, Zentrum für Molekulare Biologie, Heidelberg, Germany) and
pEFblas-tetKRAB. Stable cell lines were established by selection against
5 
 
m
 
g/ml Blasticidin S (Calbiochem) and characterized by transiently
transfected pUHD10-3–green fluorescent protein (GFP) and induction
with 200 ng/ml doxycycline for 24 h. Cyclin AN
 
D
 
170–inducible cell lines
 
were obtained by transfecting ONK2 cells with pUHD10-3-AN
 
D
 
170 and
pKJ-1 (a gift from J. Penninger, Amgen, Toronto, Canada), selected
against G-418 (1 mg/ml) and Blasticidin S (5 
 
m
 
g/ml), and characterized by
immunoblotting 24 h after induction.
 
Plasmids
 
Cyclin A was amplified by PCR from pKS-myc-Cyclin A (a gift from J.
Pines, University of Cambridge, Cambridge, UK) to remove the 9E10
epitope and introduce unique NH
 
2
 
- and COOH-terminal restriction sites.
Mouse cyclin B1 and a D-box mutant thereof were amplified from plas-
mids 1213 and 1213dm, respectively (a gift from M. Brandeis, Hebrew
University, Jerusalem, Isreal), and human Mad2 was amplified from
HeLa cell cDNA. All cDNA fragments were subcloned into the mamma-
lian expression vector pEFT7MCS (Pepperkok et al., 1999). Point muta-
tions were generated either by oligonucleotide-directed second strand
synthesis of phage R408-generated single stranded DNA or standard
PCR-based protocols (Ausubel et al., 1999) and verified by restriction di-
gests or sequencing. NH
 
2
 
- or COOH-terminal deletions were generated
by PCR. The cyclin A-GFP fusion was constructed by subcloning either a
GFP or cyan fluorescent protein (CFP) (provided by R. Tsien, University
of California at San Diego, La Jolla, CA) encoding cDNA fragment into
the COOH terminus of cyclin A. Cyclin B–yellow fluorescent protein
(YFP) fusions have been described (Pepperkok et al., 1999). GFP leaks
out of methanol-fixed cells, so we generated GFPNeo as a transfection
marker. GFPNeo was constructed by amplifying GFP and neomycin
phosphotransferase from plasmids pEFTT7-GFP and pCDNA3.1 (Invit-
rogen), respectively, with primers containing overlapping sequences and
subcloned into pEFT7MCS. We generated the bicistronic expression vec-
tor pTSIGN in which GFPNeo was expressed from the encephalomyo-
carditis virus (EMCV) interal ribosome entry site (IRES) in pEFT7MCS.
The Mad2 cDNA was cloned upstream of the EMCV-IRES and is ex-
pressed under the control of the EF1 
 
a
 
-promoter. DnBub1 was gener-
ated by amplifying the NH
 
2
 
-terminal 334 residues from the mouse Bub1
coding region (provided by S. Taylor, School of Biological Sciences,
Manchester, UK) and subcloning it into pEFT7MCS. The expression
vector for the tetracycline repressible transcriptional repressor tet-
KRAB was constructed by subcloning the coding sequence of tet-KRAB
(Deuschle et al., 1995) into the expression vector pEFblas (a gift from G.
Wahl, Salk Institute, La Jolla, CA). The expression vector for hsMad1
was a gift from T. Jeang (National Institute of Allergy and Infectious
Diseases, Bethesda, MD) (Jin et al., 1998).
 
Antibodies
 
Polyclonal (JG39) and monoclonal antibodies (E23) were raised against a
fragment of bovine cyclin A. For indirect immunofluorescence, JG39 was
used at a 1:100 dilution. Anti-cyclin B1 antibodies (V152) were used at 10
 
m
 
g/ml for immunostaining and 5 
 
m
 
g/ml for immunoblotting. E23 was used
at 2 
 
m
 
g/ml for immunoblotting. Anti-Cdc27 and anti-Cdc20 antibodies
have been described (Kramer et al., 1998; Gieffers et al., 1999) and were
used at 1 mg/ml in microinjection experiments.
 
Microinjection and Time-lapse Videomicroscopy
 
HeLa and HTB
 
H2B
 
 cells were grown in glass-bottomed 3-cm dishes
(MaTek Corp.) and microinjected using a semiautomatic Eppendorf mi-
croinjection system mounted on a ZEISS Axiovert 35 microscope. For mi-
croinjection experiments, proteins were diluted in sterile filtered PBS to 1
mg/ml and plasmid DNA in sterile filtered water to 25–100 ng/
 
m
 
l. Fluores-
cent dextran (
 
M
 
r
 
 
 
. 
 
2 MD) (Sigma-Aldrich) was used at a final concentra-
tion of 0.5 mg/ml. All samples were centrifuged for 20 min at 14,000 rpm at
4
 
8
 
C before 2 
 
m
 
l was loaded into a borosilicate capillary pulled on a P-97 mi-
cropipette puller (Sutter Instrument Co.). For live cell observations, cells
were cultured in phenol red–free medium and placed into small workshop-
made microincubation chambers fitted onto the stage of ZEISS Axiovert
135TV or Nikon inverted microscopes. The microscopes were heated to
37
 
8
 
C and equipped with a CO
 
2
 
 supply. Phase and fluorescence shutters
were controlled by Lambda 10-2 (Sutter Instrument Co.) or Ludl filter
wheels. The ZEISS microscopes were equipped with MicroMax 1300
(Roper Scientific) mounted at the bottom port, whereas the Nikon micro-
scopes had Orca I (Hamamatsu) cameras mounted at the side port. The
cooled CCD cameras were driven by IPLabSpectrum
 
 
 
P
 
 
 
(Scanalytics),
Openlab (Improvision), or AQM2000 (Kinetic Imaging) software pack-
ages. For dual color GFP imaging, we used the commercial filter set XF135
(Omega Optical, Inc.). To minimize light damage to the cells, neutral den-
sity filters were put into the light path. Time-lapse series were generated by 
Geley et al. 
 
Proteolysis of Human Cyclin A
 
139
 
taking images every 5–6 min that were then converted to 8-bit images, as-
sembled into QuickTime™ movies, and quantified using NIH Image 1.62.
 
Immunofluorescence
 
Cells grown on glass coverslips were washed in PBS and fixed with metha-
nol at 
 
2
 
20
 
8
 
C for 4 min or in 3.7% paraformaldehyde for 20 min at room
temperature and permeabilized with 0.1% Triton X-100 for 2 min. After
incubation with the primary antibodies (diluted in PBS/1% FCS/0.2%
Tween 20) for 20 min at room temperature, cells were washed twice with
PBS and incubated with secondary FITC- (Dako), Alexa 488– (Molecular
Probes), Cy3- (Sigma-Aldrich), or Alexa 546–conjugated secondary anti-
bodies. For direct immunofluorescence, affinity-purified anti-cyclin A
polyclonal rabbit serum JG39 was conjugated with Cy3 (Amersham Phar-
macia Biotech). For DNA staining, living or fixed cells were incubated
with Hoechst 33342 (Sigma-Aldrich) at 1 
 
m
 
g/ml for 10 min and then
washed in PBS. Cells were mounted using Mowiol 4-88 (Calbiochem) and
analyzed using standard FITC, rhodamine, and DAPI filter sets on a
ZEISS Axioskop microscope. Pictures were taken using an Orca I camera
(Hamamatsu) and Openlab image software (Improvision).
 
Metabolic Labeling, Immunoprecipitation,
and Immunoblotting
 
Logarithmically growing HeLa cells (10
 
5
 
/ml) were washed twice in me-
dium lacking methionine and cysteine and cultured for 30 min in this me-
dium supplemented with 10% dialyzed FCS. To label newly synthesized
proteins, 100 
 
m
 
Ci [
 
35
 
S]methionine and [
 
35
 
S]cysteine (Promix; Amersham
Pharmacia Biotech) were added for 4 h. Cells were washed three times
with PBS and then incubated in complete medium containing 2 mM cold
methionine and cysteine. For immunoprecipitation, dishes were put on
ice, rinsed with ice-cold PBS, and the cells were scraped into Eppendorf
tubes, pelleted at 1,000 
 
g
 
 for 2 min, and frozen. Extracts were prepared by
NP-40 lysis as described below. After preclearing, 2 
 
m
 
l of rabbit polyclonal
antiserum JG39 was added to 1 mg of protein, incubated for 2 h at 4
 
8
 
C,
and centrifuged at 14,000 rpm before adding 10 
 
m
 
l of Affi-Prep protein A
beads (Bio-Rad Laboratories). After incubation for 1 h at 4
 
8
 
C, beads were
pelleted and washed three times in lysis buffer, transferred to new tubes,
and washed in lysis buffer containing 500 mM NaCl. The pellet was finally
resuspended in 20 
 
m
 
l SDS sample buffer and analyzed by SDS-PAGE and
autoradiography using a PhosphorImager (Molecular Dynamics).
For immunoblotting, cell pellets were incubated for 30 min on ice in
NP-40 lysis buffer (50 mM Tris-HCl, pH 8.0, 250 mM NaCl, 20 mM
EGTA, 50 mM NaF, 100 
 
m
 
M Na
 
3
 
VO
 
4
 
, and 0.1% NP-40) and spun at
10,000 
 
g
 
 for 10 min. The soluble extracts (10–20 
 
m
 
g protein) were analyzed
by PAGE, transferred to nitrocellulose membranes, and processed by
standard immunoblotting procedures (Ausubel et al., 1999). The bands
were visualized by ECL (Amersham Pharmacia Biotech).
 
Destruction and Ubiquitylation Assays
 
Substrates for in vitro degradation assays were prepared by translating 1
 
m
 
g of in vitro T7 RNA polymerase transcribed and capped mRNA in 10
 
m
 
l of a 50:50 (vol/vol) mixture of ribonuclease-treated rabbit reticulocyte
lysate and frog egg extract (Murray, 1991) containing 5 
 
m
 
Ci [
 
35
 
S]methio-
nine and [
 
35
 
S]cysteine (Promix; Amersham Pharmacia Biotech) for 90 min
at 23
 
8
 
C. For degradation assays, 1 
 
m
 
l of substrate was added to 14 
 
m
 
l egg
extract, activated by addition of 0.4 mM CaCl
 
2
 
, and incubated at 23
 
8
 
C.
1-
 
m
 
l aliquots were diluted in 20 
 
m
 
l SDS sample buffer and analyzed by
SDS-PAGE and autoradiography.
Substrates for in vitro ubiquitylation reactions were prepared using the
Promega TnT kit and [
 
35
 
S]Promix. Recombinant human Cdh1 or Cdc20
was purified from baculovirus-infected insect cells and added to APC/C
immunopurified from interphase 
 
Xenopus
 
 egg extracts. The ubiquityla-
tion reactions were performed as described by Kramer et al. (2000).
 
Online Supplemental Material
 
The online version of this paper contains two video clips (available at http:
//www.jcb.org/cgi/content/full/153/1/137/DC1) corresponding to Fig. 8,
A and B. The first video, shows fluorescence images of HTB96 cells ex-
pressing H2B-GFP undergoing mitosis. The second video shows H2B-
GFP–expressing cells that have been injected with an expression plasmid
for stable cyclin A (Cyclin A
 
D
 
47-83) which arrest in anaphase with con-
tinuing chromosome movements. Fig. 8, A and B, show selected frames
from the videos with the times indicated in minutes. Time point “0” is ar-
bitrarily set to the first image, which does not correspond with the first
frame of the video.
 
Results
 
Cyclin A Is Stable in Interphase and Becomes Unstable 
in Mitosis
 
Cyclin A expression starts at the beginning of S phase,
and its levels rise steadily until late G2 phase, but it is ab-
sent in late mitosis and G1 phase (Pines and Hunter,
1991; Erlandsson et al., 2000). To understand the regula-
tion of cyclin A protein levels, we measured its half-life
in proliferating cells. An asynchronously growing popula-
tion of HeLa cells was labeled with 
 
35
 
S-amino acids and
transferred to nonradioactive growth medium after 4 h.
Cells were harvested at the indicated times, and immuno-
precipitates of cyclin A were analyzed by SDS-PAGE
Figure 1. Cyclin A is a relatively stable protein in
the S and G2 phase of the cell cycle. (A) HeLa cells
were labeled with 35S-amino acids and transferred
to nonradioactive medium after 4 h. At the indicated
times, cyclin A was immunoprecipitated and analyzed
by SDS-PAGE and autoradiography. X denotes a
contaminant band. (B) Quantified data from this
experiment and from cells treated with CHX and
immunoblotted for cyclin A. (C) Methanol-fixed
HeLa cells stained for cyclin A (JG39), B1 (V152),
and DNA (Hoechst 33342). G2/P, G2 or prophase;
PM, prometaphase; M, metaphase; A, anaphase.
Bar, 20 mm. 
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(Fig. 1 A). Fig. 1 B shows that the half-life of cyclin A
was 
 
$
 
12 h and that the decay showed linear rather than
exponential kinetics, consistent with a model whereby cy-
clin A is long lived in S and G2 phase but rapidly de-
graded when cells enter mitosis. We also measured the
levels of cyclin A after the addition of cycloheximide
(CHX) to an asynchronous cell culture and immunoblot-
ting (Fig. 1 B). In cells arrested in S phase with hydroxy-
urea, the levels of cyclin A stayed constant for 
 
$
 
4 h after
addition of CHX (data not shown), but after this the cells
started to die. We conclude that cyclin A is a relatively
stable protein during S and G2 phase of proliferating
cells.
However, during mitosis cyclin A disappears rapidly
from cells (Pines and Hunter, 1991). We confirmed that
prometaphase cells stained brightly for cyclin A, whereas
metaphase cells (judged by Hoechst 33342 staining) with
strong cyclin B1 staining gave variable cyclin A signals,
confirming that cyclin A is degraded before cyclin B1 (Fig.
1 C). These results suggest that cyclin A is degraded ear-
lier than cyclin B1, before the onset of anaphase, and that
its proteolysis occurs while cyclin B1 is still stable.
 
Cyclin A-GFP Destruction Begins in Prometaphase and 
Is Completed at Metaphase
 
To follow the kinetics of cyclin A destruction in real time,
cyclin A was tagged with GFP at its COOH terminus, and
the expression plasmid was injected into G2-synchronized
HeLa cells (see Materials and Methods). Fig. 2 shows that
Cyclin A-GFP concentrated in the nucleus (and formed
an active protein kinase with Cdk2 in vitro [data not
shown]) and is thus likely to behave similarly to wild-type
cyclin A. The injected cells started to accumulate nuclear
fluorescence 
 
z
 
2 h after microinjection of the expression
plasmid and entered mitosis at about the same time as
neighboring uninjected cells. The fluorescence signal of
cyclin A-GFP started to decline uniformly throughout the
cell after nuclear envelope breakdown (NEBD). Cyclin
A-GFP signals were very much reduced in metaphase
cells (Fig. 2 A, top).
For comparison, a similar study was made using mouse
cyclin B2-YFP. Cyclin B2-YFP was located in the cyto-
plasm in interphase cells and translocated into the nucleus
 
z
 
10 min before NEBD. Cyclin B2-YFP levels continued
to rise slightly in prometaphase localized to the mitotic
Figure 2. Degradation of cyclin-GFP in living cells. (A) Expression vectors for cyclin A-GFP (top) and cyclin B2-YFP (bottom) were
injected into G2 phase HeLa cells and followed by time-lapse videomicroscopy. The graph shows the quantified data for cyclin A-GFP,
cyclin B2-YFP, and GFPNeo-expressing cells from prophase until cytokinesis. (B) Dual color GFP tagging of cyclins. Cyclin A-CFP
was coexpressed with cyclin B1-YFP and analyzed by sequential image acquisition. (C) Cyclin A (red) and cyclin B1 (green) destruc-
tion. Cyclin A-CFP and cyclin B1-YFP were injected into G2 phase HeLa cells and analyzed by time-lapse fluorescence microscopy.
Images were pseudocolored and merged. The time course and quantified data of one of the cells going through mitosis (arrow) are
shown. Bars, 20 mm. 
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spindle and were stable until metaphase and declined rap-
idly in anaphase (Fig. 2 A, bottom).
The expression of cyclin A-GFP often delayed the onset
of anaphase (we return to this point below; see Fig. 9) which,
in the cell shown in Fig. 2 A, occurred 
 
$
 
20 min later than in
 
the cell expressing cyclin B2-YFP. A comparison of cyclin A
and B degradation rates was therefore only possible be-
tween cells in which the duration of mitosis was not grossly
altered. Fig. 2 A compares the kinetics of loss of GFP-
tagged cyclins A and B in two different cells that had a simi-
lar length of mitosis from NEBD to cytokinesis (the graph
shows fluorescence values for one out of four quantified
cells). Cyclin A destruction preceded that of cyclin B by 30–
40 min. To enable simultaneous measurements to be made
in the same cell, cyclin A was fused to CFP and mouse cyclin
B1 to YFP, and the plasmids were coinjected into G2-syn-
chronized HeLa cells (see Materials and Methods). Fig. 2 B
shows that the CFP and YFP signals were well separated,
and Fig. 2 C shows that cyclin A started to be degraded
shortly after NEBD and reached low levels in metaphase
when cyclin B1 started to become unstable. The graph in
Fig. 2 C shows the YFP and CFP levels of one out of three
quantified cells and indicates that cyclin A degradation pre-
cedes that of cyclin B1 by 
 
z
 
30 min. These observations
agree with those of den Elzen and Pines in this issue (2001).
 
Cyclin A Destruction Is Dependent on the APC/C but 
Is Insensitive to the Spindle Assembly Checkpoint
 
To test if the APC/C was required for the degradation of cy-
clin A, we injected G2-synchronized HeLa cells with affinity-
purified anti-Cdc27 antibodies which arrested a high fraction
of them at metaphase (Fig. 3 A). Of 68 cells injected with
anti-Cdc27 antibodies, 55 arrested in mitosis. None of the
control IgG-injected cells had arrested when analyzed 14 h
after injection. To determine the effect of anti-Cdc27 anti-
bodies on cyclin levels, cells were fixed with methanol and
stained for cyclin A and B1. Cyclin A was present at high
levels in the majority of these cells (69 out of 88 injected and
arrested cells), suggesting that it was a target of the APC/C
(Fig. 3 B). Next, antibodies against human Cdc20 or Cdh1
were injected into the nucleus of synchronized HeLa cells
and the cells were stained for cyclin A and B1 14 h later. In-
jection of anti-Cdc20 antibodies also caused cells to accumu-
late in metaphase but with lower efficiency than anti-Cdc27
antibodies, probably indicating that the arrest was transient.
Nevertheless, both cyclin A (19 out of 27 injected cells) and
B1 (16 out of 16 injected cells) were readily detectable (Fig. 3
C) in the anti-Cdc20 metaphase-arrested cells. Anti-Cdh1
antiserum had no detectable effect on mitosis or cyclin deg-
radation (data not shown). When cyclin A-GFP expression
plasmid (25 ng/
 
m
 
l) was coinjected with either anti-Cdc27 or
anti-Cdc20 antiserum, the GFP signal remained high in
metaphase-arrested cells (data not shown).
These results suggested that cyclin A is a target of the
Cdc20-associated APC/C in human cells. To test more di-
rectly whether the APC/C is able to recognize cyclin A as
a substrate, we set up an in vitro ubiquitylation reaction
for cyclin A in which immunopurified APC/C from acti-
vated 
 
Xenopus laevis
 
 egg extracts was added to radiola-
beled cyclin A (see Materials and Methods). Addition of
recombinant Cdc20 or Cdh1 promoted rapid and efficient
conversion of cyclin A into high molecular weight ubiq-
uitin conjugates (Fig. 3 D), confirming that cyclin A is a
target of the Cdc20-activated APC/C.
The activity of the APC/C is controlled by the spindle
assembly checkpoint and disruption of the mitotic spindle
by microtubule poisons leads to Mad2-dependent inactiva-
Figure 3. Cyclin A is an APC/C substrate. (A and B) HeLa cells
were injected with antibodies against Cdc27 and stained with
Hoechst 33342 after 14 h. A compares phase–contrast and Hoechst
fluorescence images. Panel B shows staining for cyclin A, B1,
and Hoechst 33342. Injected cells (arrow) were arrested at
metaphase with high levels of cyclin A. (C) Anti-Cdc20 antibodies
were injected with FITC-labeled dextran. Cells were analyzed for
cyclin A 14 h later. The asterisk indicates a noninjected
metaphase cell that lacks cyclin A. The arrowheads indicate cells
that were injected with lower amounts of antibodies and contain
low amounts of cyclin A; the full arrows indicate arrested cells
with high levels of cyclin A. (D) Ubiquitylation assay. 35S-labeled
cyclin A was added to an ubiquitylation reaction containing im-
munopurified APC/C activated by Cdc20 or Cdh1 as indicated.
Samples were analyzed at the indicated times by SDS-PAGE
and autoradiography. Bars, 20 mm. 
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tion of the APC/C’s ability to ubiquitylate securin and cy-
clin B. Fig. 4 A shows that in cells exposed to nocodazole
or taxol cyclin B1 levels were maintained, but the levels of
cyclin A fell. The low levels of cyclin A in taxol- or no-
codazole-treated cells were due to proteolytic degrada-
tion, since addition of the proteasome inhibitor MG132
led to accumulation of cyclin A in the arrested cells (25 of
27 cells were positive, whereas only 2 of 34 cells were posi-
tive before addition of MG132) (Fig. 4 A bottom; data not
shown). Even when cyclin A-GFP was overexpressed from
a strong heterologous promoter, it did not accumulate in
nocodazole-arrested cells, whereas cyclin B1-YFP did
(data not shown).
We next asked whether overexpression of spindle as-
sembly checkpoint effector proteins, which are thought to
act by inhibiting Cdc20-APC/C, would stabilize cyclin A.
Expression plasmids for hsMad1 and hsMad2 were micro-
injected into synchronized HeLa cells during G2 phase
and filmed by time-lapse videomicroscopy. A metaphase
arrest of 
 
$
 
6 h was observed, but cells were apt to die after
this. Cyclin B1 was detected in all of the arrested cells
(data not shown), whereas significant levels of cyclin A
were only seen in 3 of 21 arrested cells, and most of the
metaphase-arrested cells had very low levels (Fig. 4 B).
This indicates that the mitotic block imposed by overex-
pression of Mad1 and Mad2 or the activation of the spin-
dle assembly checkpoint with microtubule poisons inhibits
the degradation of cyclin B1 but does not delay the pro-
teolysis of cyclin A.
 
The Delay in the Degradation of Cyclin B1 Relative to 
Cyclin A Depends on the Mitotic Checkpoint
 
In animal cells, the spindle assembly checkpoint is acti-
vated during prometaphase (Chen et al., 1996) and re-
mains active until all the chromosomes have established a
bipolar orientation on the mitotic spindle (Rieder et al.,
1994, 1997). The observation that cyclin A is destabilized
in prometaphase and is a target of the APC/C suggests
that the APC/C is active in prometaphase. To test if the
spindle assembly checkpoint is responsible for delaying cy-
clin B1 degradation, we expressed a dominant negative
version of the mouse checkpoint kinase Bub1 together
with cyclin B1-YFP. Fig. 5 shows that dnBub1 caused pre-
cocious disappearance of cyclin B1-YFP which was now
degraded shortly after NEBD. The difference in cyclin B1
Figure 4. Cyclin A is unstable in nocodazole- and taxol-treated
cells. (A) HeLa cells exposed to inhibitors. G2 phase HeLa cells
were treated with nocodazole (Noc) for 14 h or taxol for 4 h until
cells accumulated in mitosis. MG132 (100 mM) was added to the
taxol-treated cells and incubated for an additional 2 h, after
which cells were stained for DNA and cyclin B1 and A. (B) HeLa
cells transfected with Mad1 and 2. G2 HeLa cells were injected
with an expression vector for human Mad1 and a bicistronic ex-
pression vector that expressed Mad2 and GFPNeo (pTSIGN-
Mad2) and were stained for DNA or cyclin A 14 h later.
Metaphase-arrested GFP positive cells are indicated by arrows.
Bars, 20 mm.
Figure 5. Dominant negative Bub1 accelerates the degradation of
cyclin B1-YFP. Expression plasmids for the NH2-terminal domain
of mouse Bub1 and cyclin B1-YFP were coinjected into G2 phase
HeLa cells and followed through mitosis. (A) A sequence of im-
ages of a cell going through mitosis. (B) Quantitation of B1-YFP
signal during mitosis with one out of four cells monitored. Filled
squares indicate cyclin B1-YFP fluorescence in control cells; open
diamonds indicate the presence of dnBub1. Bar, 20 mm. 
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degradation relative to that of cyclin A thus seems to de-
pend on the spindle assembly checkpoint which selectively
delays the degradation of cyclin B, and presumably that of
securin, until chromosomes are correctly aligned on the
mitotic spindle.
 
The D-Box of Cyclin A
 
To understand how the APC/C is able to distinguish be-
tween cyclin A and B, we analyzed the D-box of cyclin A.
Like the B-type cyclins, cyclin A possesses a sequence in its
NH
 
2 
 
terminus that was identified as a D-box because muta-
tion or deletion of the conserved RXXL sequence in clam
cyclin A or 
 
Xenopus
 
 cyclin A1 strongly stabilized the protein
(Luca et al., 1991; Lorca et al., 1992; Stewart et al., 1994). We
used 
 
Xenopus
 
 egg extracts to analyze the D-box of human
cyclin A2. These extracts are arrested at metaphase due to
the activity of cytostatic factor (CSF) and can be released
into anaphase by addition of CaCl
 
2
 
 (see Murray, 1991). Sur-
prisingly, human cyclin A was unstable in the majority of egg
extracts, although addition of CaCl
 
2
 
 accelerated its proteoly-
sis (Fig. 6 B). This suggests that cytostatic factor–arrested ex-
tracts resemble nocodazole-arrested cells, in that APC/C ac-
tivity is present at a level sufficient to degrade cyclin A,
although cyclin B is stable. Point mutations in the conven-
tional D-box motif (Adb3, R47A/L50A/N57A) or even de-
letion of residues 45–58, which comprise the entire canonical
D-box (Fig. 6 B), failed to stabilize human cyclin A2 in the
egg extracts. Deletion of the NH
 
2
 
-terminal 60 residues did
not stabilize human cyclin A, but deletions of the first 80 res-
idues gave a stable protein (data not shown). In contrast, a
double point mutation in the D-box of mouse cyclin B1
(RTALG to GTAVG, labeled B1dm in Fig. 6) completely
stabilized it under the same conditions (Fig. 6 B).
Deletion of residues 47–83 or 45–72 stabilized human
cyclin A (Fig. 6 B), whereas 
 
D
 
60-80 was still unstable (data
not shown). Thus, the cis element of cyclin A required for
proteolysis starts with the canonical D-box and includes an
additional motif present between residues 60 and 72. As
we found previously for 
 
Xenopus
 
 cyclin A1, degradation
of human cyclin A2 in vitro required binding to a Cdk,
since mutants defective in binding a Cdk partner, for ex-
ample, a cyclin box mutant (R211L) or a small COOH-ter-
minal deletion (
 
D
 
C28), were stable in the frog extract as-
say (data not shown).
The degradation of both cyclin A and B1 was delayed
but not abolished when affinity-purified anti-Cdc20 anti-
bodies were added to the extract 30 min before adding the
substrates, indicating that both are dependent on Cdc20-
associated APC/C (Fig. 6 B). We also tested the cyclin A
mutants in the in vitro ubiquitylation assay (see Fig. 3 D).
Fig. 6 C shows that wild-type cyclin A, mutant 
 
D45-58, and
the NH2-terminal deletion mutant AND60 were efficiently
(.50%) converted into high molecular weight ubiquity-
lated forms after 5 min. In contrast, the R211L (MLAIL)
and AD47-83 deletion mutant, which were stable in frog
anaphase extracts, were very poorly ubiquitylated.
Fig. 6 D shows an alignment of A-type cyclins from a vari-
ety of species and reveals that the extended D-box motif in
human cyclin A is conserved among the somatic A-type cy-
clins of human, cattle, mouse, and hamster but not in Xeno-
pus cyclin A2 or chicken cyclin A (Fig. 6 D). It is also absent
Figure 6. Cyclin A2 has a novel D-box. (A) Cyclin A deletion
mutants. Schematic representation of cyclin A and mutants ana-
lyzed in this study. (B) Destruction assays. In vitro–translated
and –labeled cyclins were added to frog egg extracts and incubated
at 238C in the presence or absence of 0.4 mM CaCl2. Samples were
analyzed by SDS-PAGE and autoradiography. (C) Ubiquitylation
assays. Cdc20-dependent ubiquitylation in vitro. High molecular
weight forms of cyclin A were quantified by fluorography of the
dried SDS gels. (D) D-box alignments. Alignment of the NH2-
terminal regions of A-type cyclins surrounding the D-box,
whose conserved residues (R47, L50, and N57) are marked by
filled circles. The deletion mutants referred to in the text are
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in all embryonic or A1-type cyclins, suggesting that the deg-
radation of cyclins A1 and A2 might be regulated differently.
The stability of some of these mutants was checked in
living cells using GFP fusion proteins. The mutant of cyclin
A lacking just the classical D-box (AD45-58–GFP), like
wild-type cyclin A-GFP was rapidly degraded in mitosis,
and did not accumulate in nocodazole-arrested cells (data
not shown), indicating that deletion of the classical D-box
does not stabilize cyclin A in vivo. In contrast, cyclin
AD47-83–GFP was stable in mitosis (see below) and accu-
mulated in nocodazole-arrested cells (data not shown).
Nondegradable Cyclin A Arrests Cells in Anaphase
We next tested the effects of nondegradable cyclin A on
cell cycle progression. HeLa cells were transfected with an
expression vector for various cyclin constructs together
with a GFPNeo marker. Neither wild-type cyclin A nor an
inactive (Cdk nonbinding mutant R211L [Stewart et al.,
1994]) arrested cells in mitosis when GFP-positive cells
were analyzed 48–72 h after transfection (Fig. 7 A). By
contrast, the nondegradable forms of cyclin A, AND170 or
AD47-83, arrested cells in mitosis, similarly to the cyclin
B1 D-box mutant (Fig. 7 A). We generated cell lines with
tetracycline-regulated expression of cyclin AND170. After
induction for 24 h, cyclin AND170 accumulated to three to
five times the levels of endogenous cyclin A (Fig. 7 B), and
cells rounded up and arrested in mitosis (Fig. 7 B, bottom).
To follow chromosome behavior in real time in cells ex-
pressing indestructible cyclin A, we generated a cell line
that expressed a histone H2B-GFP fusion protein (Kanda
et al., 1998). Fig. 8 A shows that these cells normally take
30 min from the first sign of chromosome condensation to
the onset of anaphase. Synchronized HTB96H2B-GFP cells
were microinjected with expression plasmids for cyclin
Figure 7. Stable cyclin A arrests cells in mitosis. (A) HeLa cells
were transfected with a mixture of GFPNeo and cyclin constructs
as indicated and cultured for 48 h. Cyclin-GFP plasmids were
transfected without a marker. Cells were fixed, stained for DNA,
and counted as being in interphase (black bars), mitosis (white
bars), or dead (gray bars) as judged by Hoechst 33342 staining.
(B) Tetracycline-inducible cyclin AND170 expression. Cyclin
A-ND170–inducible clones derived from HTB96 cells were in-
duced with 200 ng/ml doxycycline (Dox) for 24 h and analyzed
by immunoblotting for cyclin A. Phase–contrast images of clone
3 cells grown in the absence (left) or presence (right) of 200 ng/ml
doxycycline for 24 h. Cells arrested in mitosis appear round and
refractile. Bar, 200 mm.
Figure 8. Stable cyclin A arrests cells in anaphase. (A) Time-
lapse analysis of an H2B-GFP–expressing HTB96 cell going
through mitosis. (B) H2B-GFP–expressing cells were injected
in G2 phase with DNA encoding cyclin AD44-83 and TRITC-
dextran as an injection marker. The arrowhead marks a cell that
was arrested in anaphase for .2 h. The arrow marks a cell that
underwent an abortive cytokinesis at 215 min but failed to decon-
dense its chromosomes. Bars, 20 mm.Geley et al. Proteolysis of Human Cyclin A 145
AD47-83 and rhodamine-labeled dextran as an injection
marker. Fig. 8 B shows cells expressing AD47-83 (arrow-
head) which showed a slight delay in the onset of anaphase
and final arrest in anaphase. After initiation of anaphase
(Fig. 8 B, arrowhead A) cells apparently separated their
sister chromatids, but cytokinesis did not occur. Instead,
arrested cells exhibited rapid movements of chromosomes
that appeared to be clustered in two main groups, indicat-
ing that they were still attached to their spindle poles. This
is best seen in the videos available at http://www.jcb.org/
cgi/content/full/153/1/137/DC1.
Fig. 9 summarizes the kinetics of mitosis in several
HTB96H2B-GFP cells expressing wild-type cyclin A or various
cyclin A mutants. Surprisingly, the onset of anaphase in
cells expressing wild-type cyclin A was often delayed for up
to several hours before mitosis was completed. A similar
transient inhibitory effect on the onset of anaphase was also
observed in cells expressing cyclin A-MLAIL and A-F304S,
a mutant that activates Cdk2 very poorly (data not shown).
This indicates that kinase activity associated with cyclin A is
not required for this delay, whereas its D-box is necessary
since cells expressing cyclin AD47-83 entered anaphase with
almost the same kinetics as control cells (Fig. 9).
Discussion
In this paper, we analyze the timing and mechanism of cy-
clin A proteolysis in cultured somatic cells. We show that
cyclin A degradation starts as cyclin B enters the nucleus,
is insensitive to the spindle assembly checkpoint, and nor-
mally precedes the proteolysis of cyclin B by z30 min. The
metaphase to anaphase transition is not initiated until cy-
clin A levels are extremely low and overexpression of
wild-type cyclin A blocked cells in metaphase. Surpris-
ingly, however, this arrest did not depend on the kinase ac-
tivity normally associated with cyclin A and expression of
active forms of cyclin A containing deletions of the D-box
blocked cells in anaphase.
Despite the striking differences between the timing of
cyclin A and B proteolysis, they both appear to be de-
graded as a result of polyubiquitylation by the Cdc20-
dependent form of the APC/C. The ubiquitylation of cy-
clin A in cell-free assays was rapid and efficient with immu-
nopurified APC/C and Cdc20 (or Cdh1), and there is pres-
ently no good evidence for alternative pathways for cyclin
A proteolysis. Thus, even though a fraction of cyclin A is
associated with the Skp1/Cullin/F-box protein complex
(SCF) ubiquitin ligase (Zhang et al., 1995; Bai et al., 1996),
cyclin A is a relatively stable protein with a half-life of .12 h
during S and G2 phase. Cells of Skp2-deficient mice accu-
mulate cyclin E but not cyclin A (Nakayama et al., 2000).
We are tempted to speculate that the cyclin A/Cdk2 in
the SCF complex is the protein kinase that tags substrates
(for example, Cdc6) for degradation (Petersen et al., 1999;
Willems et al., 1999; Coverley et al., 2000), although it is
also possible that cyclin A activity is regulated by the SCF
(Yam et al., 1999).
In  Drosophila, cyclin A degradation requires the fzy
gene (Dawson et al., 1995; Sigrist et al., 1995) and in both
Saccharomyces cerevisiae and Xenopus (Fang et al., 1998b),
Cdc20 (fzy) is required for the activation of the APC/C,
and it was recently reported that Cdc20 bound directly to
the NH2 terminus of cyclin A, although the D-box was not
required for this interaction (Ohtoshi et al., 2000). Sub-
strates of the APC/C are typically characterized by their
possession of a nine-residue motif known as the D-box
(RxxLxxxxN) (Glotzer et al., 1991). The NH2 terminus
of cyclin A contains a D-box–like sequence, R47AALA-
VLKSGN57. Unlike the embryonic form of cyclin A1 in
Xenopus (Lorca et al., 1992; Stewart et al., 1994), human
cyclin A2 was not stabilized even by deletion of the entire
“classical” D-box (D45-58). Further mutational analysis re-
vealed that an adjacent domain 10–20 residues downstream
was required for the degradation of cyclin A. Thus, the
D-box of human cyclin A appears to be significantly larger
than those of frog cyclin A1 or the B-type cyclins. This en-
larged D-box seems to require a correctly folded cyclin box
for efficient recognition by the APC/C, which may or may
not reflect a need for binding to a Cdk partner.
Cyclin A Degradation Is Independent of the Spindle 
Assembly Checkpoint
Even when cyclin A was expressed from a strong hetero-
logous promoter, it could not be detected in nocodazole-
arrested cells. Thus, cyclin A is degraded when the spindle
assembly checkpoint is strongly activated. Even overexpres-
sion of Mad2, which inhibited the metaphase–anaphase
transition and stabilized cyclin B1, did not prevent cyclin A
proteolysis. Conversely, dominant negative Bub1, which in-
hibits the mitotic checkpoint, advanced the degradation of
cyclin B1-YFP so that it showed kinetics of dissappearance
similar to those of cyclin A under normal conditions (al-
though for reasons of technical difficulty, we have not ex-
amined the kinetics of cyclin A proteolysis in cells express-
ing dnBub1). We suspect that, even under these conditions,
cyclin A would still disappear earlier than cyclin B, as it
does in Xenopus egg extracts in which the mitotic check-
point is not operative (Minshull et al., 1990, 1994). We con-
clude from these experiments that the APC/C is activated as
cells enter mitosis, and the mitotic checkpoint selectively
delays the degradation of cyclin B1 (and by implication,
that of securin) until all of the chromosomes are correctly
aligned on a well-formed mitotic spindle.
Figure 9. Timing of anaphase
onset. Cyclin A degradation is
required for the onset of
anaphase. H2B-GFP–express-
ing cells were injected with
expression plasmids for cyclin
A, AD47-83, A-F304S, or
A-MLAIL together with
TRITC-labeled dextran and
monitored by time-lapse
videomicroscopy. The hori-
zontal lines represent the time
that individual cells spent in
mitosis from prometaphase
until the onset of anaphase.
Each line represents a single
cell: ,, onset of anaphase; 0,
anaphase arrest; //,, delay of #90 min until anaphase onset; //,
delay of #200 min or the end of the recording time. Filled
squares denote cell death.The Journal of Cell Biology, Volume 153, 2001 146
Currently, the simplest way to explain the differences be-
tween the proteolysis of cyclin A and other APC/C sub-
strates is that cyclin A is simply a better substrate for the
APC/C than securin and cyclin B, so that cyclin A proteoly-
sis can occur even when the activity of the APC/C is held in
check by the spindle assembly checkpoint. We imagine that
a long polyubiquitin chain is required for efficient delivery
to the proteasome and that long chains result from long
dwell times at the APC/C. Thus, substrates with a lower
dissociation constant are preferentially degraded and may
even be degraded under conditions when the activity of the
APC/C is reduced by the operation of the checkpoint. This
view is consistent with the long delays in metaphase pro-
duced by overexpression of wild-type but not NH2-termi-
nally truncated cyclin A. Apparently, securin and cyclin B
are unable to compete with cyclin A for the APC/C. Test-
ing this hypothesis will require further work, but it is con-
sistent with the differences in the D-boxes. Larger D-boxes
potentially make more contacts, and the additional require-
ment for functional cyclin A–Cdk complexes as substrates
suggests the existence of additional contacts between the
APC/C and cyclin A that would promote tighter binding
and longer dwell times, allowing more highly processive ad-
dition of ubiquitin moieties.
Cyclin A Degradation Is Required for the Onset of 
Anaphase and Exit from Mitosis
The ability of overexpressed cyclin A to delay the onset of
anaphase was not dependent on functional kinase activity,
since cyclin A mutants unable to bind to or activate Cdks
also efficiently blocked cells at metaphase. In addition,
nondegradable cyclin A lacking its D-box (D47-83) ar-
rested cells in anaphase without grossly affecting sister
chromatid separation. This differs from what has been re-
ported for Drosophila embryos, where expression of sta-
ble cyclin A caused a significant delay at metaphase (Si-
grist et al., 1995). As the D-box of Drosophila cyclin A is
not defined and coexpression of stable cyclin B caused
Drosophila cells to arrest in anaphase, it is possible that
the NH2-terminal deletion mutant of cyclin A used in this
study was still somewhat unstable, causing a similar phe-
notype to the one we observe using wild-type cyclin A.
In summary, wild-type cyclin A seems to compete for
the degradation of substrates required for the onset of
anaphase, whereas stable cyclin A arrests cells in anaphase.
We speculate that the cyclin A–dependent delay in the on-
set of metaphase is due to direct competition with other
substrates of the APC/C such as securin. It is also possible
that overexpression of cyclin A interferes with a yet un-
known proteolytic pathway that is required to establish a
stable chromosome alignment at the metaphase plate, as
suggested by den Elzen and Pines (2001) in this issue.
Further experiments are required to define how cyclin
A interferes with the onset of anaphase and how the dif-
ferences between cyclin A and B destruction and the ap-
parent substrate specificity of the mitotic checkpoint re-
vealed by this analysis can be explained.
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